Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
P/S (TTM)
1.2
Societal CDMO, Inc., an organization founded in Exton, Pennsylvania, in 2007, functions as a contract development and manufacturing partner for the global pharmaceutical industry. Formerly known as Recro Pharma, Inc. until its name change in March 2022, the company specializes in supporting small molecule therapeutic advancements. Its comprehensive services span the entire drug development lifecycle, from initial research and development to manufacturing and packaging various therapeutic dosage forms for both domestic and international markets. Key offerings include drug development expertise, end-to-end regulatory guidance, clinical and commercial scale production, sterile fill/finish operations, freeze-drying (lyophilization), and integrated packaging and logistics solutions.
www.bendbioscience.comNo one on the platform currently holds SCTL.
No tracked institution reports a position in SCTL as of their last filing.
No one on the platform has traded SCTL yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | 4.9% | 4.1% | ||||
| Profit Margin % | -14.0% | -36.0% | ||||
| Free Cash Flow Margin % | -12.2% | -10.3% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is -1.0% on the P/E track.
At today's price, your expected annual return is +3.5% on the P/E track.
At today's price, your expected annual return is +7.4% on the P/E track.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $124M | +20.9% | $0.06 | $0.06–$0.06 | 18.3× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2024-05-08 | $-0.03 | $-0.06 | -100.0% |
| 2024-03-22 | $-0.01 | $-0.01 | +0.0% |
| 2023-11-08 | $-0.02 | $-0.05 | -150.0% |
| 2023-08-14 | $-0.03 | $-0.04 | -20.0% |
| 2023-05-10 | $-0.05 | $-0.06 | -20.0% |
| 2023-03-01 | $-0.05 | $-0.02 | +60.0% |
| 2022-11-09 | $-0.06 | $-0.06 | +0.0% |
| 2022-08-10 | $-0.08 | $-0.06 | +25.0% |
| $121M |
| — |
| OPNTOpiant Pharmaceuticals, Inc. | $20.65 | +0.00% | $109M | — |
| OPTNOptiNose, Inc. | $9.60 | +0.00% | $97M | — |
Source: Financial Modeling Prep · peers by sector/industry
🚀 Leading the Quantum Revolution with Spectral Capital! Spectral Capital is transforming cloud tech with Vogon Cloud, a decentralized, quantum-inspired platform tackling latency, security, and sustainability. 🌐⚡ With VogonID, users gain secure, self-sovereign access across the ecosystem, ensuring privacy and control. 🔒 Immediate cash flow from modular data centers, high-growth equity potential, and visionary leadership (like Dr. Wolf Kohn) position $SCTL at the forefront of quantum innovation. 📈 As cloud markets soar past $1T by 2028, Spectral is primed for explosive growth. Now’s the time to get in! 🚀📊 #QuantumComputing #CloudTech #Investing #SCTL #VogonCloud #TechStocks
View on StockTwits ↗
$SCTL Societal CDMO, Inc. (NASDAQ:SCTL): Navigating Challenges with Resilience https://beyondspx.com/article/societal-cdmo-inc-nasdaq-sctl-navigating-challenges-with-resilience
View on StockTwits ↗
$SCTL Societal CDMO investors could have been rich being attached to the Cingulate drug hype train. Too bad the leadership ran it into the ground first. Nice work guys
View on StockTwits ↗$SCTL Societal CDMO, Inc. (NASDAQ:SCTL): Navigating Challenges with Resilience http://beyondspx.com/2024/08/05/societal-cdmo-inc-nasdaqsctl-navigating-challenges-with-resilience/
View on StockTwits ↗
$SCTL I just read an article about drug shortages in the U.S. This is why I’m disgusted with this management and BOD!⬇️ While ASHP CEO Paul Abramowitz warned that all drug classes are vulnerable to drug shortages, he said that "some of the most worrying shortages involve generic sterile injectable medications, including cancer chemotherapy drugs and emergency medications stored in hospital crash carts and procedural areas." Literally the exact business Societal was in!! But they couldn’t secure any contracts?!? BS!! They weren’t trying!! To busy arranging a criminally low buyout of the business!!! They were working on selling this business for 3 yrs. It was David and Ryan’s main focus since taking over. Sickening people.
View on StockTwits ↗$SCTL Goodbye all!! It’s been real. We all got hosed by David and Ryan and the BOD. This company should have been worth $3-$5.00/share after the debt refinance and supposed land sale that never came through. David made a lot of mistakes and got paid handsomely to do it. I wish the SEC would do their jobs and start holding these people accountable for stealing peoples money. Never ever invest in a company that Ryan Lake is associated with. He’s a destroyer of lives!! ✌🏻
View on StockTwits ↗
$SCTL CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc. https://www.stocktitan.net/news/SCTL/core-rx-inc-completes-acquisition-of-societal-cdmo-6sg87573tv37.html
View on StockTwits ↗
$SCTL still have my 56k shares. Fuck Societal forever
View on StockTwits ↗$SCTL You know, all the public and or private offerings held within the last 2 yrs or so, knew of these inquiries into buying this company. Retail investors weren’t privy to this information. So these companies like First Light and a few others were getting in at .40 and knew they had offers of at least double that amount. So of course they are going to buy in. David and Ryan and the BOD were working on this for several years too. I believe 2021 or so. After watching the show Suits and the documentary on Uber, I wouldn’t be surprised if David Enloe wasn’t a plant by someone to set this whole transaction up from the start! We would never know. Tank the stock price, institutional investors and hedge funds and insiders get in dirt cheap, make a couple decent deals to prop up the company, and then turn around and sell the company for triple what they bought in at. Of course they positioned themselves to make sure they had enough votes or shares to be tendered to pass the deal.
View on StockTwits ↗$SCTL Is this halted until they announce whether or not the buyout went through??
View on StockTwits ↗
$SCTL trade halt (T12) was alerted to our Members at 7:50pm EDT. Halt price: $1.09 Vol: 514.62K.
View on StockTwits ↗$SCTL still have my 56k shares. Fuck you David and Ryan.
View on StockTwits ↗$SCTL Sold all but 5 shares… These criminal fuckers are gonna get the correct karma eventually.🙏🏻😤
View on StockTwits ↗$SCTL Price going up as we get closer to April 5, 2024. You must tender your shares by… Please take action, or make any chan ges to your selection by April 4, 2024, 7:00 p.m. ET.
View on StockTwits ↗$SCTL For anyone following this thread(SCTL), could you please indicate whether you have tendered or are intending to tender your shares by April 4, 2024. I don’t know what to do, and I hold 15k shares currently. Just please indicate “tendered” or “not tendering”. Thank you!
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.